Gauzy appoints Alejandro Weinstein to board of directors

Gauzy (GAUZ) announced changes to its Board of Directors following the Company’s annual general meeting of shareholders. The shareholders of the Company have elected longtime company investor and former Board member Alejandro Weinstein, to return to the Board as a Director with his term commencing November 1, 2025. Weinstein previously served as CEO of CFR Pharmaceuticals. Gal Gitter concluded his service on the Board following the expiration of his term as a Class I Director. In addition, long-time Director and Board member, Danny Allouche is stepping down from the Board.